FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to method of differential diagnosis of diseases with oncological and non-oncological genesis. Summary: method involves measuring electrophoretic mobility of erythrocytes and decrease of electrophoretic mobility of erythrocytes by less than 49 % of physiological norm is diagnosed disease of not oncological genesis. At reduction of electrophoretic mobility of erythrocytes by more than 50 % of physiological standard disease of oncological genesis is diagnosed, with physiological norm equal to 1.75±0.04 mqm·cm/V·s.
EFFECT: using declared invention enables more effective differential diagnosis of diseases with oncological and non-oncological genesis.
1 cl, 2 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIFFERENTIAL DIAGNOSTICS OF MALIGNANT NEOPLASMS AND SOMATIC NONMALIGNANT DISEASES | 2006 |
|
RU2335768C2 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF MALIGNANT NEOPLASMS AND SOMATIC NONMALIGNANT DISEASES | 2002 |
|
RU2232391C2 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ACUTE PANCREATITIS | 2016 |
|
RU2637637C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING BENIGN AND MALIGNANT NEOPLASMS IN INTERNAL FEMALE SEXUAL ORGANS | 2006 |
|
RU2323439C1 |
METHOD FOR SCREENING MALIGNANT NEOPLASMS IN HUMANS | 2017 |
|
RU2665965C1 |
METHOD FOR DETECTING TUMOR RISK GROUP AND MAKING EARLY STAGE TUMOR DISEASE CASES SCREENING | 1997 |
|
RU2137420C1 |
MINIMALLY INVASIVE METHOD FOR DIAGNOSTICS OF LUNG CANCER ON BASIS OF CHANGING COPY NUMBER OF MTDNA HV2 LOCUS | 2018 |
|
RU2678227C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2011 |
|
RU2469333C1 |
METHOD OF DIAGNOSTICS OF CANCER IN CATS AND DOGS | 2010 |
|
RU2480748C2 |
METHOD OF DIAGNOSTICS OF MALIGNANT NEOPLASMS OF THE BRAIN | 2017 |
|
RU2673659C1 |
Authors
Dates
2016-07-27—Published
2015-06-10—Filed